Latest News Releases From The Newsroom
Pre-Market Waves: WiSA Tech Surges on WiSA E Availability; 2seventy bio Tumbles on AML Trial Pause
June 14th, 2023
WiSA Technologies, Inc. (Nasdaq: WISA) said that it is now accepting pre-orders for its WiSA E development kits, featuring advanced wireless audio transmission and reception capabilities utilizing the 5GHz Wi-Fi band. This cutting-edge technology pro. Read more
Blue Water Biotech Ignites Momentum with Acquisition, while Plug Power Makes Waves in Pre-Market
June 14th, 2023
Blue Water Biotech, Inc. (Nasdaq: BWV) has signed an Asset Purchase Agreement with WraSer, LLC and Xspire Pharma, LLC for the acquisition of six FDA-approved assets in various medical fields, including cardiology, otic infections, and pain management. Read more
BTIG: Potential Upside On SOFI, UPST, PYPL, OPRT, and JKHY
June 14th, 2023
SoFi Technologies, Inc. (NASDAQ: SOFI), a fintech company offering a wide range of financial services including lending, investing, and banking, has been initiated with a Buy rating by BTIG, who announced a price target of $14. Despite $SOFI. Read more
Piper Sandler: Opportunity on DPZ, SBUX, CMG, PTLO, SHAK, BSY, PTC, YUM, and WEN
June 14th, 2023
Domino's Pizza, Inc. (NYSE: DPZ), a leading global pizza delivery and carryout chain, has been initiated with an Overweight rating by Piper Sandler, who also announced a price target of $349. With $DPZ closing at $301.89 on Tuesday, this pri. Read more
House Chairman McCaul Advocates for Release of Evan Gershkovich, Condemns Putin's Regime and Wrongful Detentions
June 13th, 2023
House Foreign Affairs Committee Chairman Michael McCaul passionately addressed the House Floor yesterday, advocating for the immediate release of Evan Gershkovich, a U.S. citizen and respected journalist who has been wrongfully detained by the Russia. Read more
Inventiva: Promising Lanifibranor Trial Data; Bullish View Towards 89bio, BRP, CompoSecure
June 13th, 2023
Inventiva S.A. (Nasdaq: IVA), a pharmaceutical company, has announced encouraging results from a Phase II clinical trial evaluating lanifibranor in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2D). Th. Read more
Intevac Seeks Strategic Options; Agile Therapeutics Enhances Twirla Access
June 13th, 2023
Intevac, Inc. (Nasdaq: IVAC) has engaged Houlihan Lokey Capital, Inc. as an investment banking firm to provide guidance and strategic advice to the company's management and board of directors regarding strategic options to maximize stockholder value.. Read more
IperionX Inks SoW with Ford; Upbeat Analyst View for Jabil, HubSpot, APA, and Toast
June 13th, 2023
IperionX Limited (Nasdaq: IPX), a company specializing in the supply of titanium metal components, has reached a a Scope of Work (SoW) agreement with Ford Motor Company (NYSE: F) to supply titanium metal components using IperionX's unique 100% recycl. Read more
President Biden Hails Positive May Consumer Price Index Report
June 13th, 2023
President Joe Biden is pleased with the latest May Consumer Price Index report, as it indicates positive developments for hardworking families. The report highlights ongoing progress in addressing inflation while maintaining historically low unemploy. Read more
Pre-Market Momentum: Silo Pharma and Netflix
June 13th, 2023
Silo Pharma, Inc. (Nasdaq: SILO) has made an important stride in the field of medical research by entering into a research and development agreement to explore the potential of a dosage and time-release ketamine implant for the treatment of fibromyal. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025
Member Login